跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hertraz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hertraz
Approved
STANDARD
Hertraz
Biocon Biologics India Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
edffc277f957afdb
Company
Biocon Biologics India Limited.
Type
Standard
Approval Details
Approval Id
edffc277f957afdb
Drug Approval Philippines Name
Hertraz
Product Name
Hertraz
Registration Number
BR-1240
Brand Name
Hertraz
Generic Name
Trastuzumab
Dosage Form
Powder for Concentrate for Solution for Infusion (IV)
Dosage Strength
150 mg
Manufacturer
Biocon Biologics India Limited.
Trader
Biocon Biologics Limited
Importer
Zuellig Pharma Corporation.
Distributor
Zuellig Pharma Corporation.
Trader Detail Path
/organization/biocon-biologics-limited
Issuance Date
28 January 2025
Expiry Date
05 October 2027
Pharmacologic Category
Monoclonal Antibodies
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
edffc277f957afdb
Type
Standard
Back to Philippines FDA Approvals